Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Kangmei Pharmaceutical Company    600518   CNE0000017M1

KANGMEI PHARMACEUTICAL COMPANY

(600518)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
09/16/2019 09/17/2019 09/18/2019 09/19/2019 09/20/2019 Date
3.57(c) 3.75(c) 3.94(c) 4.14(c) 4.08 Last
33 635 794 61 659 683 48 311 523 31 824 821 185 428 455 Volume
-0.28% +5.04% +5.07% +5.08% -1.45% Change
More quotes
Financials (CNY)
Sales 2019 -
EBIT 2019 -
Net income 2019 -
Debt 2019 -
Yield 2019 -
Sales 2020 -
EBIT 2020 -
Net income 2020 -
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 -
Capi. / Sales2020 -
Capitalization 20 293 M
More Financials
Company
Kangmei Pharmaceutical Company develops, produces, and sells pharmaceutical products intended primarily for treating hypertension and colds. The group offers Chinese medications (ginseng, salvia, codonopsis, etc.) and chemical medications (clarithromycin, doxazosin mesylate, paracetamol, etc.). 
Sector
Pharmaceuticals
Calendar
10/28Earnings Release
More about the company
Latest news on KANGMEI PHARMACEUTICAL COM
05/21KANGMEI PHARMACEUTICAL : China's Kangmei Pharma sinks by daily limit as watchdog..
RE
05/17Chinese firms' missing $6 billion tests regulators' resolve
RE
03/28As China pushes traditional medicine globally, illegal wildlife trade flouris..
RE
2013MARKET COMMENT : China Shares Fall 0.2%, But Narrow Earlier Losses
DJ
More news
Sector news : Pharmaceuticals - NEC
09/20DR REDDY LABORATORIES : . Reddy's Suspends Shipments of Ranitidine
DJ
09/20ALLERGAN : Form 8.3 -
DJ
09/20NOVO NORDISK : FDA Approves Novo Nordisk's Rybelsus Diabetes Tablets
DJ
09/20ZOETIS : Says EC Grants Marketing Authorization for Antiparasitic Medication for..
DJ
09/20MERCK : Pfizer Get CHMP Positive Opinion for Bavencio
DJ
More sector news : Pharmaceuticals - NEC
Chart KANGMEI PHARMACEUTICAL COMPANY
Duration : Period :
Kangmei Pharmaceutical Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KANGMEI PHARMACEUTICAL COM
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 4,08  CNY
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Xing Tian Ma Chairman & General Manager
Jia Qian Luo Chairman-Supervisory Board
Yi Qing Zhuang Chief Financial Officer & Head-Accounting
Dong Jin Xu Vice Chairman & Deputy General Manager
Han Yao Ma Director
Sector and Competitors
1st jan.Capitalization (M$)
KANGMEI PHARMACEUTICAL COMPANY-55.70%2 862
JOHNSON & JOHNSON2.01%347 446
ROCHE HOLDING LTD.16.27%245 289
MERCK AND COMPANY11.45%218 042
PFIZER-15.95%202 934
NOVARTIS15.60%199 009